Matches in Wikidata for { <http://www.wikidata.org/entity/Q95648238> ?p ?o ?g. }
- Q95648238 description "article scientifique publié en 2020" @default.
- Q95648238 description "artículu científicu espublizáu en mayu de 2020" @default.
- Q95648238 description "scientific article published on 23 May 2020" @default.
- Q95648238 description "wetenschappelijk artikel" @default.
- Q95648238 description "наукова стаття, опублікована 23 травня 2020" @default.
- Q95648238 name "Reduced-intensity conditioning is a reasonable alternative for Philadelphia chromosome-positive acute lymphoblastic leukemia among elderly patients who have achieved negative minimal residual disease: a report from the Adult Acute Lymphoblastic Leuk" @default.
- Q95648238 name "Reduced-intensity conditioning is a reasonable alternative for Philadelphia chromosome-positive acute lymphoblastic leukemia among elderly patients who have achieved negative minimal residual disease: a report from the Adult Acute Lymphoblastic Leuk" @default.
- Q95648238 type Item @default.
- Q95648238 label "Reduced-intensity conditioning is a reasonable alternative for Philadelphia chromosome-positive acute lymphoblastic leukemia among elderly patients who have achieved negative minimal residual disease: a report from the Adult Acute Lymphoblastic Leuk" @default.
- Q95648238 label "Reduced-intensity conditioning is a reasonable alternative for Philadelphia chromosome-positive acute lymphoblastic leukemia among elderly patients who have achieved negative minimal residual disease: a report from the Adult Acute Lymphoblastic Leuk" @default.
- Q95648238 prefLabel "Reduced-intensity conditioning is a reasonable alternative for Philadelphia chromosome-positive acute lymphoblastic leukemia among elderly patients who have achieved negative minimal residual disease: a report from the Adult Acute Lymphoblastic Leuk" @default.
- Q95648238 prefLabel "Reduced-intensity conditioning is a reasonable alternative for Philadelphia chromosome-positive acute lymphoblastic leukemia among elderly patients who have achieved negative minimal residual disease: a report from the Adult Acute Lymphoblastic Leuk" @default.
- Q95648238 P1433 Q95648238-BFEA89B7-9EC8-4156-A3F8-A3C2719D9BF6 @default.
- Q95648238 P1476 Q95648238-ACF727DE-DE25-4F10-AFA4-B3A4801051C8 @default.
- Q95648238 P2093 Q95648238-17587EC8-F2AE-48C5-B31A-A4BD1B8C2BDA @default.
- Q95648238 P2093 Q95648238-412D0585-51E2-4A97-9E9F-3FC77372DF92 @default.
- Q95648238 P2093 Q95648238-5B425235-0E4A-49C2-9D80-BE283012B338 @default.
- Q95648238 P2093 Q95648238-8E0A9494-869E-42D0-86FA-8DE42D1C1751 @default.
- Q95648238 P2093 Q95648238-EC0058A7-E169-483B-A28B-2E5A18D91D2B @default.
- Q95648238 P2093 Q95648238-ED5D4C14-8B8E-44E4-B088-8086E4C40EBB @default.
- Q95648238 P2093 Q95648238-F46F7CA2-F33F-4C6E-A60E-205450B4E425 @default.
- Q95648238 P2093 Q95648238-FBC7F2BA-087F-477B-8026-67BA03000AB5 @default.
- Q95648238 P2860 Q95648238-07AAAC83-87A8-4C20-BD86-33DB6C102E4E @default.
- Q95648238 P2860 Q95648238-07AC7508-E37C-40E2-A7ED-E68533464780 @default.
- Q95648238 P2860 Q95648238-07C22F91-C4B3-4C5D-A36E-6D3A5FCB5DB9 @default.
- Q95648238 P2860 Q95648238-0DC08066-A0C8-4668-88E8-5CA7C6A3B7B9 @default.
- Q95648238 P2860 Q95648238-213D763B-6D35-4E2E-8CF7-2653FE82A148 @default.
- Q95648238 P2860 Q95648238-23E1F2D1-5B4E-4F17-9DEA-D9DB94E127F7 @default.
- Q95648238 P2860 Q95648238-2FE86EF6-1FF8-4C5D-9983-88B0D4FB6E80 @default.
- Q95648238 P2860 Q95648238-362C3214-D74B-48A2-B25B-3C5FCF627380 @default.
- Q95648238 P2860 Q95648238-38F02B73-F33C-44EA-BA7D-49A6D3A0AEC6 @default.
- Q95648238 P2860 Q95648238-3D96AB62-21C3-4D49-AA21-0009BAA990F7 @default.
- Q95648238 P2860 Q95648238-3F5B508A-09B3-4BFD-9642-D2F848EB7336 @default.
- Q95648238 P2860 Q95648238-438655DF-B0F4-406B-9BB9-5EB3729CE797 @default.
- Q95648238 P2860 Q95648238-44B8E0C3-DB15-410F-BE70-2170FC549F86 @default.
- Q95648238 P2860 Q95648238-487E4D29-452A-49C0-B77F-78EEE2D0F9FC @default.
- Q95648238 P2860 Q95648238-4AB5BE78-506D-48EC-B5D2-9CD0DA787CFA @default.
- Q95648238 P2860 Q95648238-4F7EC0BE-A4AA-43AD-8F8C-1CD603E9A0A3 @default.
- Q95648238 P2860 Q95648238-533D2202-6CC2-4E9E-B6CA-E793E92099A7 @default.
- Q95648238 P2860 Q95648238-579C202C-B0BE-4DA0-9CAA-7F71737668F8 @default.
- Q95648238 P2860 Q95648238-5844F92E-6CAD-4A46-B752-CB2C0ABBC7B6 @default.
- Q95648238 P2860 Q95648238-5AAF88AE-E099-43E2-B057-24B7F935AB08 @default.
- Q95648238 P2860 Q95648238-5B0CF663-E8E4-47F2-BBA3-DF63276B148C @default.
- Q95648238 P2860 Q95648238-600E5892-78BF-4C0E-8DC0-7EE41473592C @default.
- Q95648238 P2860 Q95648238-67DAD205-EAAD-4797-8B4F-71DACCAF534F @default.
- Q95648238 P2860 Q95648238-6C88489E-58D4-4DDF-883B-A7FD4E7DC08E @default.
- Q95648238 P2860 Q95648238-6F78C67E-2B11-4FC9-BB82-6172664674E4 @default.
- Q95648238 P2860 Q95648238-7DBB74EA-602E-4B28-A50E-3E37CE32B5C8 @default.
- Q95648238 P2860 Q95648238-831CBC14-A207-4E40-808B-CABF7F988CFB @default.
- Q95648238 P2860 Q95648238-9155A6F0-D7BD-463B-AA8B-69C35D3FB383 @default.
- Q95648238 P2860 Q95648238-9229A1E3-EB82-4E33-8D3E-D1DD4A071996 @default.
- Q95648238 P2860 Q95648238-A5B5E517-B480-4FA9-8353-78C9B4E3F9EE @default.
- Q95648238 P2860 Q95648238-AF9D8CB5-F0CB-4D31-8448-F74882DA3B55 @default.
- Q95648238 P2860 Q95648238-B71BDB68-DF56-49E7-92DC-A37ADFAF1747 @default.
- Q95648238 P2860 Q95648238-BC71736B-B8BB-4818-B09D-403CF83F7FD4 @default.
- Q95648238 P2860 Q95648238-BF56A971-32CD-444E-98D4-BF262C903F6C @default.
- Q95648238 P2860 Q95648238-D038D885-1907-4AC8-8CAD-BE83E8CCAEF2 @default.
- Q95648238 P2860 Q95648238-D1FAE032-F3EB-4C90-8451-F9D2D9A27F3D @default.
- Q95648238 P2860 Q95648238-D66CF992-E7FB-42F2-A00C-62E42977814D @default.
- Q95648238 P2860 Q95648238-DB914B9D-FBFB-4ED4-99B0-A526C13FDE57 @default.
- Q95648238 P2860 Q95648238-DC0E9B71-5048-42D4-87F0-C512B65AB784 @default.
- Q95648238 P2860 Q95648238-DD0592C3-23C3-42CB-B446-2A960FB2F4FE @default.
- Q95648238 P2860 Q95648238-E34B302A-4F82-46D4-A1D0-89548B73A404 @default.
- Q95648238 P2860 Q95648238-F6A5DBD2-95FA-46F0-A591-1B9B2FA17EA0 @default.
- Q95648238 P2860 Q95648238-F90FC585-6A35-405B-97BF-D73970A4024B @default.
- Q95648238 P2860 Q95648238-FA06DC6A-9BB6-43BC-9B54-FD7A5EE1D295 @default.
- Q95648238 P2860 Q95648238-FD709249-B6D0-479F-8616-FC8F94890576 @default.
- Q95648238 P2860 Q95648238-FE9540CB-66B3-4242-87D5-5D9372D8E269 @default.
- Q95648238 P31 Q95648238-1B2564A4-A9BC-4803-93F8-8175535F73B4 @default.
- Q95648238 P356 Q95648238-BBD1F07F-194C-4C7C-8179-AD8C118BD253 @default.
- Q95648238 P50 Q95648238-33C123BB-7584-4165-9C7C-28F61A205F78 @default.
- Q95648238 P50 Q95648238-4556F789-39B4-49E4-B124-2DA54BBB831E @default.
- Q95648238 P50 Q95648238-46EF8528-41DC-4B7B-962E-47672EC714AC @default.
- Q95648238 P50 Q95648238-5471FB23-DFA6-463F-8A4D-548C1DB04B5A @default.
- Q95648238 P50 Q95648238-6D5BB17A-7EA9-48BB-8A62-D0692DD58B5C @default.
- Q95648238 P50 Q95648238-6E760C3D-3159-47B9-9300-364C061D6831 @default.
- Q95648238 P50 Q95648238-F147F4EB-4843-499B-8DF1-2A5CCCAA5D41 @default.
- Q95648238 P577 Q95648238-7663E973-0D24-46EA-965B-4F1C07D3A8EA @default.
- Q95648238 P698 Q95648238-211AFFC3-687D-4FF3-BED5-B1F8C05AA8B9 @default.
- Q95648238 P921 Q95648238-3D8C7295-2F0C-4EC9-8AEE-B1C8F3550BFB @default.
- Q95648238 P356 S41409-020-0951-0 @default.
- Q95648238 P698 32447350 @default.
- Q95648238 P1433 Q4941523 @default.
- Q95648238 P1476 "Reduced-intensity conditioning is a reasonable alternative for Philadelphia chromosome-positive acute lymphoblastic leukemia among elderly patients who have achieved negative minimal residual disease: a report from the Adult Acute Lymphoblastic Leukemia Working Group of the JSHCT" @default.
- Q95648238 P2093 "Junji Tanaka" @default.
- Q95648238 P2093 "Kaito Harada" @default.
- Q95648238 P2093 "Masatsugu Tanaka" @default.
- Q95648238 P2093 "Naoyuki Uchida" @default.
- Q95648238 P2093 "Shuichi Ota" @default.
- Q95648238 P2093 "Takahiro Fukuda" @default.
- Q95648238 P2093 "Yoshiko Atsuta" @default.
- Q95648238 P2093 "Yoshinobu Kanda" @default.
- Q95648238 P2860 Q24685958 @default.
- Q95648238 P2860 Q26828511 @default.
- Q95648238 P2860 Q31019536 @default.
- Q95648238 P2860 Q31026869 @default.
- Q95648238 P2860 Q33813439 @default.
- Q95648238 P2860 Q33843477 @default.
- Q95648238 P2860 Q33917170 @default.
- Q95648238 P2860 Q35031141 @default.